Alex Tatara, MD PhD
amtatara.bsky.social
Alex Tatara, MD PhD
@amtatara.bsky.social
Physician scientist engaged in biomaterials, immunoengineering, and device-related infection.
Assistant prof at UTSW.
Had a wonderful time speaking with the 90+ high schoolers about that came to UTSW BME STARS day! Everyone enjoyed learning about osteomyelitis and orthopedic tissue engineering. Thank you to UTSW BME for hosting! @utswinfdis.bsky.social
October 30, 2025 at 10:01 AM
Reposted by Alex Tatara, MD PhD
Patient-reported perceptions, experiences and preferences around intravenous and oral antibiotics for the treatment of Staphylococcus aureus bacteremia: a descriptive qualitative study.

✅ Just Accepted
#IDSky
🔗 https://bit.ly/3Iil2JB
September 27, 2025 at 8:50 PM
Reposted by Alex Tatara, MD PhD
My team’s new article is out!

For male basic trainees who had ICD-10 code for UTI or dysuria:

~50% had a sexual history documented
~70% had a gc/ct test ordered,
-Ultimate diagnosis of gc/ct >>> uti
-Few had any STI testing in 3 years following dysuria

#IDSky

academic.oup.com/milmed/advan...
Testing for Sexually Transmitted Infections in Symptomatic Male Military Trainees
AbstractIntroduction. A high burden of sexually transmitted infections (STIs) exists among trainees entering United States Air Force Basic Military Trainin
academic.oup.com
August 10, 2025 at 10:26 PM
Many thanks for highlighting our work and giving us the opportunity to talk about the exciting intersection between host, microbe, and biomaterial!
July 14, 2025 at 6:48 PM
Reposted by Alex Tatara, MD PhD
Many thanks to Jay Vyas for writing such an insightful commentary to our article in Clinical Infectious Diseases- pubmed.ncbi.nlm.nih.gov/40470539/.
June 12, 2025 at 12:39 PM
Reposted by Alex Tatara, MD PhD
Congrats to our fantastic ID fellow (Dr. Hannah Blanchard) and ID Faculty (Dr. Hayden Andrews, Dr. Netanya Utay) on their timely publication in @cidjournal.bsky.social on Measles immunity at our HIV clinic!! 👏
academic.oup.com/cid/advance-...

@bradcutrellmd.bsky.social @netanyautay.bsky.social
June 4, 2025 at 1:51 AM
Reposted by Alex Tatara, MD PhD
@steventong.bsky.social presents the results of the PSSA domain of the SNAP 🫰 trial - the worlds largest trial of staph aureus bacteremia - at #ESCMID2025

fluclox resulted in higher mortality and more AKI compared to penicillin for PSSA
April 12, 2025 at 2:45 PM
Reposted by Alex Tatara, MD PhD
We’ve got something in review that addresses this question (as much as observational data can). Basically we think all ASPs the same compared to cefazolin
April 12, 2025 at 8:48 PM
Reposted by Alex Tatara, MD PhD
Dr Steven Tong presents data on Penicillin vs (Flu)Cloxacillin for penicillin sensitive S.aureus.

1. Penicillin is non-inferior.
2. Rate of AKI roughly half in Penicillin group.
3. More pts in Penicillin group changed Rx - why?
#ESCMIDGlobal
April 12, 2025 at 3:13 PM
Reposted by Alex Tatara, MD PhD
#ESCMIDGlobal starts soon 🤓
There's a new latebreaker session created to give 2-3 'big' trials their due: 'Trial Run', Sat 16:15
2 #SNAP trials + CloCeBa trial will be discussed in real detail Moderators @vancefowler.bsky.social +Julia Bielicki. @gurujosh.bsky.social @steventong.bsky.social #IDSky
April 8, 2025 at 2:33 PM
Reposted by Alex Tatara, MD PhD
Staphylococcus aureus bacteremia has a case fatality rate of 15% to 30% and causes 300 000 deaths per year worldwide. This Review discusses management of S aureus bacteremia. https://ja.ma/3RF8b50
Staphylococcus aureus Bacteremia: A Review
This narrative review summarizes current evidence on the epidemiology, pathophysiology, clinical presentation, diagnosis, and treatment of Staphylococcus aureus bacteremia.
ja.ma
April 7, 2025 at 3:35 PM
We reviewed the latest in ID/Ortho collaborative models- institutional investment is important! www.sciencedirect.com/science/arti... @utswinfdis.bsky.social
Models of Musculoskeletal Infection Care: The Importance of Multidisciplinary Collaboration
www.sciencedirect.com
April 6, 2025 at 7:33 PM
Come join us! Hiring a postdoc to work on immunotherapy to prevent and treat orthopaedic infection. I'll be at SFB2015 in Chicago if you want to chat about life in Dallas at our fabulous program. lnkd.in/evpKR5KE
lnkd.in/e7K2PMgh
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
April 1, 2025 at 1:41 AM
Reposted by Alex Tatara, MD PhD
🔍 Study on 47 kids with musculoskeletal infections vs. 48 Lyme & 49 inflammatory arthritis. A 3-cytokine panel (IL-6, IL-17A, CSF-1) had AUC 0.90, outperforming 5 common biomarkers (P < .05).##idsky
Utility of Cytokine Biomarkers for the Diagnosis of Pediatric Pyogenic Musculoskeletal Infections
Pyogenic musculoskeletal infections, such as septic arthritis and osteomyelitis, require prompt recognition and treatment but can be challenging to distinguish from Lyme or inflammatory arthritis. Our goal was to identify cytokine biomarkers of musculoskeletal infections.MethodsUsing 2 multicenter prospective cohorts of children undergoing emergency department evaluation for musculoskeletal infection, we selected children ≤21 years of age with a musculoskeletal infection (cases) matched by age and sex to children with Lyme and inflammatory arthritis (controls). We performed a 45-cytokine/chemokine panel using the Olink proximity extension assay platform and used receiver operator curve analysis to evaluate the discriminative ability of each cytokine. Using forward stepwise logistic regression, we derived a 3-cytokine panel and compared the accuracy with 5 commonly available plasma biomarkers.ResultsWe included 47 children with musculoskeletal infection, 48 with Lyme arthritis, and 49 with inflammatory arthritis. Interleukin-6 had the highest accuracy for musculoskeletal infection (area under the curve [AUC], 0.84; 95% CI, 0.77–0.91). A 3-cytokine biosignature panel (interleukin-6, interleukin-17A, and colony stimulating factor–1) had the highest overall accuracy (AUC, 0.90; 95% CI, 0.84–0.96) and performed better than 5 common plasma biomarkers (white blood cell count, absolute neutrophil count, C-reactive protein, erythrocyte sedimentation rate, and procalcitonin; P < .05 for all comparisons).ConclusionsPlasma cytokines can distinguish musculoskeletal infections from Lyme or inflammatory arthritis and may assist initial decision-making for children undergoing evaluation for musculoskeletal infection.
academic.oup.com
April 1, 2025 at 12:00 AM
Reposted by Alex Tatara, MD PhD
Excited to announce that we randomised our first patient in the @roadmaptrial.bsky.social today! First of thousands, answering important questions in prosthetic joint infection. See roadmaptrial.com for more deets. #IDSky #PJI #ROADMAP
Welcome to the ROADMAP Trial – Examining treatments for PJI
Explore our website to learn more about our trial, team, and how you can get involved in shaping the future of PJI treatment.
roadmaptrial.com
March 24, 2025 at 10:16 AM
Reposted by Alex Tatara, MD PhD
Post-hoc analysis of 📷 📷 study in MSSA/MRSA bacteremia:

Persistent fever = indicator for complicated infection

Fever on Day 4️⃣: aOR (3.7 (95% CI: 1.58-8.67)) mortality
Fever on Day 7️⃣: aOR: (8.78 (95% CI: 2.78-27.7)

🚫 assn between ⬆️CRP/WBC and mortality

#IDSky

academic.oup.com/ofid/advance...
Association of daily body temperature, white blood cell count, and C-reactive protein with mortality and persistent bacteremia in patients with Staphylococcus aureus bacteremia: a post-hoc analysis of...
AbstractIntroduction. Classification of patients with Staphylococcus aureus bacteremia (SAB) as complicated versus uncomplicated is based on a combination
academic.oup.com
January 31, 2025 at 2:33 AM
Reposted by Alex Tatara, MD PhD
In OFID, Seongman Bae and colleagues elucidate risk factors associated with 30-day infection-attributable mortality in a large cohort of patients with Staphylococcus aureus bacteremia (SAB).
Risk Factors for Infection-Attributable Mortality in Patients With Staphylococcus aureus Bacteremia: A Competing Risk Analysis
buff.ly
January 9, 2025 at 5:01 PM
Reposted by Alex Tatara, MD PhD
【Mayo Clinic CME Orthopedic Infectious Diseases 2025】

👉Comprehensive #OrthoID learning course is coming soon!

👉Great learning opportunity for #IDFellow #IMResident #OrthoResident!

ce.mayo.edu/orthopedic-s...

#IDMedEd #IDFellow #OrthoID #MayoClinicINFD #MSIS #EBJIS
December 31, 2024 at 1:41 AM
Reposted by Alex Tatara, MD PhD
#NIH funding is vital and the returns are superb, as noted by critical translational breakthroughs relevant to chronic fatigue, Parkinson's, prior diseases, cataracts, and hearing loss made with NIH funding in 2024
www.nih.gov/news-events/...
2024 NIH Research Highlights - Promising Medical Findings
NIH findings with potential for enhancing human health include insights into the mechanisms of ME/CFS, a skin test to detect Parkinson’s disease and related disorders, and a promising target for catar...
www.nih.gov
December 27, 2024 at 5:26 PM
Reposted by Alex Tatara, MD PhD
It's that time of year again. Here are my top 10 ID papers of 2024
1. My opinion
2. Practice changing, paradigm-shifting or dogma challenging
3. Not COVID
4. Alphabetical order by first author
5. CoI for 4 and 5 (I am an author)
Summary slide here, details in thread
#IDSky #Top10IDpapers
December 23, 2024 at 2:42 AM
Reminder that there’s a whole Vulfpeck Xmas album in the style of Guaraldi:

m.youtube.com/watch?v=mMjo...
A Very Vulfy Christmas (full album)
YouTube video by Woody Goss
m.youtube.com
December 22, 2024 at 6:30 PM